BGIM
MJN

Boussard & Gavaudan Investment Management’s Mead Johnson Nutrition Company MJN Stock Holding History

Boussard & Gavaudan Investment Management’s Portfolio MJN Stock Details MJN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-174,023
Closed -$15.5M – 20
2017
Q1 		$15.5M Buy
174,023
+143,360
+468% +$11.8M 1.9% 5
2016
Q4 		$2.17M Sell
30,663
-229,302
-88% -$17.1M 0.51% 7
2016
Q3 		$20.5M Sell
259,965
-2,893
-1% -$247K 4.22% 4
2016
Q2 		$23.8M Sell
262,858
-35,262
-12% -$2.99M 6.82% 4
2016
Q1 		$25.2M Buy
298,120
+32,923
+12% +$2.45M 13.61% 3
2015
Q4 		$21M Sell
265,197
-15,200
-5% -$1.2M 26.29% 2
2015
Q3 		$19.7M Sell
280,397
-95,160
-25% -$7.83M 32.04% 2
2015
Q2 		$34M Sell
375,557
-155,800
-29% -$15M 36.92% 2
2015
Q1 		$53.7M Sell
531,357
-14,146
-3% -$1.43M 33.69% 2
2014
Q4 		$55.4M Buy
545,503
+358,112
+191% +$35.7M 35.56% 2
2014
Q3 		$18M Buy
+187,391
New +$17.8M 10.52% 3

Other funds holding MJN

PAMU
Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $22.7B AUM
FNBOO
First National Bank of Omaha Omaha, Nebraska $3.55B AUM 27.24% 1-Year Est. Return
LFAS
Level Four Advisory Services Dallas, Texas $3.54B AUM 37.12% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
CPIG
Chicago Partners Investment Group Chicago, Illinois $5B AUM 26.84% 1-Year Est. Return
WEC
Winslow Evans & Crocker Boston, Massachusetts $528M AUM 30.99% 1-Year Est. Return

Boussard & Gavaudan Investment Management's MJN Position: Q2 2017 in Review

Boussard & Gavaudan Investment Management sold out of Mead Johnson Nutrition Company (MJN) in Q2 2017, closing a stake of 174,023 shares — an estimated $15.5M sold.

Boussard & Gavaudan Investment Management first reported a position in MJN in Q3 2014 and held it in 11 quarters. The position peaked at $55.4M in Q4 2014. 7 funds tracked by Wall St. Rank hold MJN as of Q2 2017.

  • Boussard & Gavaudan Investment Management reported no remaining Mead Johnson Nutrition Company position as of Q2 2017 after selling out during the quarter.
  • Boussard & Gavaudan Investment Management sold 174,023 Mead Johnson Nutrition Company shares in Q2 2017, an estimated $15.5M.
  • Boussard & Gavaudan Investment Management first reported a position in Mead Johnson Nutrition Company in Q3 2014 and held it in 11 quarters.
  • Boussard & Gavaudan Investment Management's Mead Johnson Nutrition Company position peaked at $55.4M in Q4 2014.
  • 7 funds tracked by Wall St. Rank held Mead Johnson Nutrition Company as of Q2 2017.

Based on Boussard & Gavaudan Investment Management's 13F filing for Q2 2017, filed 18 Jul 2017.